Of note, patients diagnosed with ACC, KIRC, MESO, SKCM, and UCEC cancer types and advanced—American Joint Committee on Cancer (AJCC) stage III and IV tumors who had high UBQLN4 mRNA levels showed a worse prognosis than patients with low UBQLN4 mRNA levels (Figure S2A–E, Table S1). Here, UBQLN4 is linked to cancer.